nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—Dysphoria—Varenicline—nicotine dependence	0.0802	0.172	CcSEcCtD
Phenylpropanolamine—DRD1—Dopamine receptors—DRD2—nicotine dependence	0.0486	0.0925	CbGpPWpGaD
Phenylpropanolamine—Coordination abnormal—Varenicline—nicotine dependence	0.0353	0.0757	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Varenicline—nicotine dependence	0.0347	0.0743	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Varenicline—nicotine dependence	0.0298	0.0639	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Varenicline—nicotine dependence	0.0246	0.0527	CcSEcCtD
Phenylpropanolamine—Irritability—Varenicline—nicotine dependence	0.024	0.0515	CcSEcCtD
Phenylpropanolamine—Urinary retention—Varenicline—nicotine dependence	0.024	0.0513	CcSEcCtD
Phenylpropanolamine—Hallucination—Varenicline—nicotine dependence	0.0173	0.0371	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Varenicline—nicotine dependence	0.0156	0.0334	CcSEcCtD
Phenylpropanolamine—Vision blurred—Varenicline—nicotine dependence	0.0143	0.0306	CcSEcCtD
Phenylpropanolamine—Tremor—Varenicline—nicotine dependence	0.0142	0.0304	CcSEcCtD
Phenylpropanolamine—Agitation—Varenicline—nicotine dependence	0.0139	0.0299	CcSEcCtD
Phenylpropanolamine—Anxiety—Varenicline—nicotine dependence	0.0129	0.0276	CcSEcCtD
Phenylpropanolamine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.0126	0.0241	CbGpPWpGaD
Phenylpropanolamine—Tachycardia—Varenicline—nicotine dependence	0.0121	0.0259	CcSEcCtD
Phenylpropanolamine—Hypotension—Varenicline—nicotine dependence	0.0116	0.0248	CcSEcCtD
Phenylpropanolamine—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0115	0.022	CbGpPWpGaD
Phenylpropanolamine—Insomnia—Varenicline—nicotine dependence	0.0112	0.024	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Varenicline—nicotine dependence	0.011	0.0236	CcSEcCtD
Phenylpropanolamine—Somnolence—Varenicline—nicotine dependence	0.011	0.0236	CcSEcCtD
Phenylpropanolamine—DRD1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.011	0.0209	CbGpPWpGaD
Phenylpropanolamine—DRD1—Monoamine GPCRs—DRD2—nicotine dependence	0.0107	0.0204	CbGpPWpGaD
Phenylpropanolamine—Constipation—Varenicline—nicotine dependence	0.0106	0.0227	CcSEcCtD
Phenylpropanolamine—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.0104	0.0198	CbGpPWpGaD
Phenylpropanolamine—Feeling abnormal—Varenicline—nicotine dependence	0.0102	0.0219	CcSEcCtD
Phenylpropanolamine—ADRB1—Monoamine GPCRs—DRD2—nicotine dependence	0.00965	0.0184	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Monoamine GPCRs—DRD2—nicotine dependence	0.00944	0.018	CbGpPWpGaD
Phenylpropanolamine—Hypersensitivity—Varenicline—nicotine dependence	0.00912	0.0195	CcSEcCtD
Phenylpropanolamine—DRD1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00902	0.0172	CbGpPWpGaD
Phenylpropanolamine—Dizziness—Varenicline—nicotine dependence	0.00819	0.0175	CcSEcCtD
Phenylpropanolamine—ADRB1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00811	0.0154	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00793	0.0151	CbGpPWpGaD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00792	0.0151	CbGpPWpGaD
Phenylpropanolamine—Vomiting—Varenicline—nicotine dependence	0.00787	0.0169	CcSEcCtD
Phenylpropanolamine—Rash—Varenicline—nicotine dependence	0.00781	0.0167	CcSEcCtD
Phenylpropanolamine—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.0078	0.0149	CbGpPWpGaD
Phenylpropanolamine—Dermatitis—Varenicline—nicotine dependence	0.0078	0.0167	CcSEcCtD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00751	0.0143	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00736	0.014	CbGpPWpGaD
Phenylpropanolamine—Nausea—Varenicline—nicotine dependence	0.00735	0.0158	CcSEcCtD
Phenylpropanolamine—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00725	0.0138	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00698	0.0133	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00656	0.0125	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00635	0.0121	CbGpPWpGaD
Phenylpropanolamine—MAOA—Biological oxidations—CYP2A7—nicotine dependence	0.00613	0.0117	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0061	0.0116	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—CHRNB3—nicotine dependence	0.00607	0.0116	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—CHRNA6—nicotine dependence	0.00575	0.011	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—CHRNB3—nicotine dependence	0.00564	0.0107	CbGpPWpGaD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00543	0.0103	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—CHRNA6—nicotine dependence	0.00535	0.0102	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00525	0.00999	CbGpPWpGaD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0052	0.00991	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00518	0.00986	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00505	0.00961	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00495	0.00942	CbGpPWpGaD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00484	0.00922	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00484	0.00921	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.0045	0.00857	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00443	0.00844	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00425	0.0081	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00424	0.00807	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—GABRA4—nicotine dependence	0.00416	0.00792	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—CHRNB4—nicotine dependence	0.00399	0.0076	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00398	0.00759	CbGpPWpGaD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00394	0.00751	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0039	0.00742	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—GABRA4—nicotine dependence	0.00387	0.00736	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00385	0.00733	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—CHRNA5—nicotine dependence	0.00371	0.00706	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—CHRNB4—nicotine dependence	0.00371	0.00706	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00367	0.00698	CbGpPWpGaD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00347	0.00661	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—CHRNA5—nicotine dependence	0.00345	0.00656	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00342	0.00651	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00323	0.00615	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00322	0.00614	CbGpPWpGaD
Phenylpropanolamine—MAOA—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00315	0.00601	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—CHRNA3—nicotine dependence	0.00302	0.00576	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.003	0.00571	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00293	0.00558	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00286	0.00545	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—CHRNA3—nicotine dependence	0.00281	0.00535	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—CHRNB2—nicotine dependence	0.00266	0.00507	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00257	0.0049	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—DRD2—nicotine dependence	0.00253	0.00482	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00252	0.0048	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0025	0.00477	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—CHRNB2—nicotine dependence	0.00247	0.00471	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00245	0.00467	CbGpPWpGaD
Phenylpropanolamine—MAOA—Neuronal System—CHRNA4—nicotine dependence	0.00242	0.0046	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0024	0.00456	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00235	0.00447	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00227	0.00433	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00226	0.0043	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00225	0.00429	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Neuronal System—CHRNA4—nicotine dependence	0.00225	0.00428	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00223	0.00424	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00221	0.0042	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0022	0.0042	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00216	0.00411	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00209	0.00397	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00208	0.00397	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00208	0.00396	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00207	0.00394	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00204	0.00389	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.002	0.00381	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.00197	0.00374	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00194	0.00369	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.00187	0.00356	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00186	0.00355	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00182	0.00347	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00182	0.00347	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.00178	0.0034	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00178	0.0034	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00177	0.00338	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.00177	0.00337	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.00173	0.00329	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00169	0.00322	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.00168	0.0032	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00166	0.00316	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00165	0.00315	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.00164	0.00313	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.0016	0.00306	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00159	0.00304	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.00157	0.00299	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00156	0.00297	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00154	0.00293	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00151	0.00287	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00151	0.00287	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00143	0.00272	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0014	0.00267	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00136	0.00259	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.00135	0.00257	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.00134	0.00256	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.00133	0.00253	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.0013	0.00247	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00129	0.00246	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.00126	0.00241	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.00121	0.00231	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.00121	0.0023	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00121	0.0023	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0012	0.00228	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.00119	0.00226	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.00118	0.00225	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00106	0.00201	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—FGD1—nicotine dependence	0.00105	0.00201	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CYP2A7—nicotine dependence	0.00105	0.002	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000983	0.00187	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000977	0.00186	CbGpPWpGaD
Phenylpropanolamine—DRD1—midbrain—nicotine dependence	0.000977	0.119	CbGeAlD
Phenylpropanolamine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.000959	0.00183	CbGpPWpGaD
Phenylpropanolamine—ADRB1—cardiovascular system—nicotine dependence	0.000953	0.116	CbGeAlD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000949	0.00181	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000948	0.00181	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	0.000931	0.00177	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000929	0.00177	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.000927	0.00177	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000913	0.00174	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000908	0.00173	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000862	0.00164	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.000843	0.00161	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000837	0.00159	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000819	0.00156	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—midbrain—nicotine dependence	0.000785	0.0953	CbGeAlD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000768	0.00146	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000767	0.00146	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	0.000763	0.00145	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—cardiovascular system—nicotine dependence	0.000754	0.0915	CbGeAlD
Phenylpropanolamine—MAOA—cardiovascular system—nicotine dependence	0.000747	0.0907	CbGeAlD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000714	0.00136	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000713	0.00136	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.0007	0.00133	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000697	0.00133	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	0.000693	0.00132	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.000686	0.00131	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000677	0.00129	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.000671	0.00128	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—WASF2—nicotine dependence	0.000656	0.00125	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000648	0.00123	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000629	0.0012	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—WASF1—nicotine dependence	0.000629	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.000623	0.00119	CbGpPWpGaD
Phenylpropanolamine—DRD1—brain—nicotine dependence	0.000614	0.0745	CbGeAlD
Phenylpropanolamine—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.00061	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.00059	0.00112	CbGpPWpGaD
Phenylpropanolamine—MAOA—midbrain—nicotine dependence	0.000584	0.0708	CbGeAlD
Phenylpropanolamine—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.000577	0.0011	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	0.000566	0.00108	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.000566	0.00108	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000555	0.00106	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.000553	0.00105	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000516	0.000983	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000509	0.00097	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000504	0.00096	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.000498	0.000949	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—brain—nicotine dependence	0.000493	0.0599	CbGeAlD
Phenylpropanolamine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000477	0.000909	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000469	0.000892	CbGpPWpGaD
Phenylpropanolamine—ADRB1—brain—nicotine dependence	0.000468	0.0568	CbGeAlD
Phenylpropanolamine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000458	0.000872	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—midbrain—nicotine dependence	0.000448	0.0543	CbGeAlD
Phenylpropanolamine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000443	0.000845	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000425	0.00081	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000412	0.000785	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—DRD2—nicotine dependence	0.00041	0.00078	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—brain—nicotine dependence	0.000398	0.0483	CbGeAlD
Phenylpropanolamine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000386	0.000736	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000383	0.000729	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—brain—nicotine dependence	0.00037	0.0449	CbGeAlD
Phenylpropanolamine—ADRB1—Signaling Pathways—DRD2—nicotine dependence	0.000368	0.000701	CbGpPWpGaD
Phenylpropanolamine—MAOA—brain—nicotine dependence	0.000367	0.0445	CbGeAlD
Phenylpropanolamine—ADRB2—Signaling Pathways—DRD2—nicotine dependence	0.00036	0.000686	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000298	0.000567	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—brain—nicotine dependence	0.000281	0.0341	CbGeAlD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	0.000277	0.000527	CbGpPWpGaD
